Early progress on accelerating drug development with Claude
Web page · https://anthropic.com/research/early-progress-drug-development
First seen by Oriel on .
AI summary
Anthropic reports early partnerships and internal programs using Claude across drug discovery, manufacturing, regulatory work, and clinical planning, with promising preclinical results and plans to scale.
- Generate Biomedicines used Claude Code to design a CAR T-cell instruction sequence about 70% shorter, producing roughly 10 times more receptors and improved tumor-cell killing.
- Divergence Labs generated roughly 35,000 antibody designs in about a month; early testing found 23 binding or IgE-displacing hits, including three outperforming standard medication.
- BigHat tested about 1,010 molecule variants in 10 weeks, achieving tighter binding, improved heat stability, and over 100-fold slower clumping in selected leads.
- Enveda connected manufacturing documents to Claude, which found all 11 human-identified issues plus seven others and reduced review time by 89%.
- The work remains mostly preclinical, while Anthropic expands Claude’s use through Claude Science, credits, verification programs, and additional research partnerships.
#drug discovery #claude #biotechnology #clinical trials
Generated by gpt-5.6-sol. Check the original for details.
Metric trends
Last 30 days · Up to 120 recorded samples per source and metric, with reposts kept separate · First and latest retained
Points
Score reported by the source.
- Hacker News: 328, latest observation ; +311 over observed period since
Comments
Comment count reported by the source.
- Hacker News: 338, latest observation ; +337 over observed period since
Aliases
| Source | External ID | URL |
|---|---|---|
| Hacker News | 50265609 | https://www.anthropic.com/research/early-progress-drug-development Read discussion |